Lihong Ye

6.3k total citations · 1 hit paper
98 papers, 5.2k citations indexed

About

Lihong Ye is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lihong Ye has authored 98 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 41 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Lihong Ye's work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (14 papers) and MicroRNA in disease regulation (11 papers). Lihong Ye is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (14 papers) and MicroRNA in disease regulation (11 papers). Lihong Ye collaborates with scholars based in China, Japan and United States. Lihong Ye's co-authors include Xiaodong Zhang, Weiying Zhang, Xiaoli Cai, Ming Cui, Shuqin Zhang, Ling Qiao, Tiejun Zhao, Yuen Gao, Shuai Zhang and Zhili Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Lihong Ye

95 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g

2017 390 citations Xiaoli Cai, Yuen Gao et al. Cancer Letters profile →

Peers

Countries citing papers authored by Lihong Ye

Since Specialization

Citations

This map shows the geographic impact of Lihong Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Ye more than expected).

Fields of papers citing papers by Lihong Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihong Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Ye. The network helps show where Lihong Ye may publish in the future.

Co-authorship network of co-authors of Lihong Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Ye. A scholar is included among the top collaborators of Lihong Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Ye. Lihong Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HBXIP induces PARP1 via WTAP-mediated m6A modification and CEBPA-activated transcription in cisplatin resistance to hepatoma 2024 ·Acta Pharmacologica Sinica ·(unknown), (unknown), (unknown), (unknown), Xue Wang, (unknown), Ye Li, Weiying Zhang, Lihong Ye	0
2	Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade 2016 ·Cancer Research ·Yu Zhao, Hang Li, Yingyi Zhang, Leilei Li, Runping Fang, Yinghui Li, Qian Liu, Weiying Zhang, (unknown), Fabao Liu, Xiaodong Zhang, Lihong Ye	82
3	HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc 2016 ·Cancer Research ·Yinghui Li, Zhen Wang, Hui Shi, Hang Li, Leilei Li, Runping Fang, Xiaoli Cai, Bowen Liu, Xiaodong Zhang, Lihong Ye	110
4	MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3′UTR 2016 ·Biochemical and Biophysical Research Communications ·Yuan Wang, Fuquan Chen, Man Zhao, Zhe Yang, Shuqin Zhang, Lihong Ye, Hongwei Gao, Xiaodong Zhang	42
5	Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9–Mediated RXRA Signaling Pathway 2015 ·Cancer Research ·Ming Cui, Zelin Xiao, Yue Wang, Minying Zheng, Tianqiang Song, Xiaoli Cai, Baodi Sun, Lihong Ye, Xiaodong Zhang	309
6	MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA 2015 ·Biochemical and Biophysical Research Communications ·Weiying Zhang, Zhanping Lu, Yuen Gao, Lihong Ye, Tianqiang Song, Xiaodong Zhang	25
7	MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA 2015 ·Biochemical and Biophysical Research Communications ·Zhanping Lu, Weiying Zhang, Shan Gao, (unknown), Zelin Xiao, Lihong Ye, Xiaodong Zhang	45
8	The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling 2014 ·Cancer Letters ·Yinghui Li, Zhao Zhang, Xiaolei Zhou, Leilei Li, Qian Liu, Zhen Wang, Xiao Bai, Yu Zhao, Hui Shi, Xiaodong Zhang, Lihong Ye	51
9	The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells 2014 ·Cancer Letters ·Yue Wang, Ming Cui, Xiaoli Cai, Baodi Sun, Fabao Liu, Xiaodong Zhang, Lihong Ye	30
10	MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR 2014 ·Acta Pharmacologica Sinica ·Yue Wang, Ming Cui, Baodi Sun, (unknown), Xiaodong Zhang, Lihong Ye	56
11	The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1 2014 ·International Journal of Oncology ·(unknown), Xiaoming Zhu, (unknown), Xiaona You, Fabao Liu, Lihong Ye, Xiaodong Zhang, Xiaohong Wang, Yuanqing Yao	31
12	Hepatitis B Virus X Protein Drives Multiple Cross-Talk Cascade Loops Involving NF-κB, 5-LOX, OPN and Capn4 to Promote Cell Migration 2012 ·PLoS ONE ·Xuan Zhang, Xiaona You, Qi Wang, Tao� Zhang, Yumei Du, Na Lv, Zhao Zhang, Shuai Zhang, Changliang Shan, Lihong Ye, Xiaodong Zhang	30
13	Down-Regulation of Myosin Light Chain Kinase Expression in Vascular Smooth Muscle Cells Accelerates Cell Proliferation: Requirement of Its Actin-binding Domain for Reversion to Normal Rates 2012 ·Journal of Pharmacological Sciences ·Hong‐Hui Wang, Akio Nakamura, Shinji Yoshiyama, Ryoki Ishikawa, Na Cai, Lihong Ye, Hiromi Takano‐Ohmuro, Kazuhiro Kohama	3
14	Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18 2012 ·Journal of Biological Chemistry ·Yumei Du, Guangyao Kong, Xiaona You, Shuai Zhang, Tao Zhang, Yuen Gao, Lihong Ye, Xiaodong Zhang	310
15	miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3′UTR of CD46 2010 ·Cancer Biology & Therapy ·Wenjing Cui, Yiwen Zhang, Nan Hu, Changliang Shan, Shuai Zhang, Weiying Zhang, Xiaodong Zhang, Lihong Ye	54
16	A mutant of HBx (HBxΔ127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase 2010 ·Acta Pharmacologica Sinica ·(unknown), Weiying Zhang, Lihong Ye, Xiaodong Zhang	17
17	Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model 2008 ·Cell Research ·Ling Qiao, Zhili Xu, Tiejun Zhao, Zhigang Zhao, Mingxia Shi, Robert Chunhua Zhao, Lihong Ye, Xiaodong Zhang	325
18	Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse transcriptase in human mesenchymal stem cells 2008 ·Acta Pharmacologica Sinica ·(unknown), Sha Li, Lihong Ye, Xiaodong Zhang	16
19	Nicotinic Acetylcholine Receptor α7 Subunit Mediates Migration of Vascular Smooth Muscle Cells Toward Nicotine 2004 ·Journal of Pharmacological Sciences ·Sheng Li, Tiejun Zhao, Hong Xin, Lihong Ye, Xiaodong Zhang, Hideyuki Tanaka, Akio Nakamura, Kazuhiro Kohama	36
20	Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077. 2000 ·PubMed ·Anjali Tikoo, (unknown), Lisa Connolly, (unknown), (unknown), Bill Bowers, Lihong Ye, Kazuhiro Kohama, Richard J. Simpson, Hiroshi Maruta	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact